Key facts
- Advanced Bifurcation Systems’s last known valuation is $31.0M (Dec 2020).
- It has raised $31.8M; the latest was Later Stage VC ($20.8M) in Jan 2025.
- Notable investors include Capital Factory, MaRS Investment Accelerator Fund, Cedars-Sinai, Brandon Holdings.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Advanced Bifurcation Systems
- ·The full record, as it builds
Funding rounds
No funding rounds for Advanced Bifurcation Systems are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Advanced Bifurcation Systems
Developer of a stenting device intended to provide an answer that overcomes the limitations of current approaches for the treatment of bifurcation lesions in coronary angioplasties. The company offers a modular, independently movable dual-catheter system for provisional side-branch stenting, enabling cardiologists to avoid positioning and mechanical problems and reduce risk, improve clinical outcomes, save procedure time, recovery time, and reduce cost.
- Sector
- Healthcare
- HQ
- Livermore, CA, United States
- Founded
- 2010
- Employees
- 17
- Website
- advancedbifurcation.com/
- Ownership
- Privately Held (backing)
Advanced Bifurcation Systems doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Advanced Bifurcation Systems shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Advanced Bifurcation Systems in its N-PORT filings yet. We sweep new filings monthly.